Ignite Creation Date:
2024-05-06 @ 10:55 AM
Last Modification Date:
2024-10-26 @ 12:37 PM
Study NCT ID:
NCT03388099
Status:
COMPLETED
Last Update Posted:
2019-12-20
First Post:
2017-12-22
Brief Title:
Impact of Gonadotrophin REceptor Polimorphisms on the Relationship Between Serum AMH and Ovarian Response
Sponsor:
Instituto Valenciano de Infertilidad IVI VALENCIA
Organization:
Instituto Valenciano de Infertilidad IVI VALENCIA
Study Overview
Official Title:
Impact of Gonadotrophin REceptor Polimorphisms on the Relationship Between Serum AMH and Ovarian Response
Status:
COMPLETED
Status Verified Date:
2019-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
GREPAMOR
Brief Summary:
Aim of study To compare the relationship between serum AMH and ovarian response for IVF with the GnRH antagonist protocol in patients who are carriers of FSH andor LH receptor polymorphisms with those that are not
Detailed Description:
Serum AMH has shown to have a high predictive capability of the ovarian response to stimulation for IVF On the other hand patients who are carriers of polymorphisms in the FSH and LH receptors have shown to need higher doses of gonadotrophins for ovarian stimulation The proportion of carriers has been described to be around 20 of the population Nevertheless the determination of these polymorphisms is not performed in routine practice It is unknown if their presence affects to the relationship between serum AMH levels and ovarian response
This is a prospective single center non-interventional cohorts study
This is a prospective single center non-interventional cohorts study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None